About Us

Most advances in drug development originate in academia but universities struggle to translate their discoveries into novel therapeutics. We aim to create a virtual accelerator platform that helps scientists bridge the valley of death and bring more diverse treatments to patients. We are building a global network of researchers, experts and partners to create a new and more scalable process for translational science.


Paul Kohlhaas

Co-Founder & CEO

Tyler Golato

Co-Founder & Chief Scientist

Titian Steiger

Co-Founder & CPO

Scientific Advisors

Paul Kohlhaas

Allison Randall

Director at Open Source Initiative

Paul Kohlhaas

Amanda McPherson

Former CMO of the Linux Foundation

Paul Kohlhaas

Andrew Updegrove

Licensing & High-Tech Intellectual Property Expert

Paul Kohlhaas

Jack Scannell

Associate Fellow at the Centre for the Advancement of Sustainable Medical Innovation at Oxford University

Paul Kohlhaas

Jonathan Darrow

Intellectual Property Expert, Assistant Professor at Harvard Medical School

Paul Kohlhaas

Morten Scheibye-Knudsen

Associate Professor at the University of Copenhagen

Open Positions